The global prevalence of chronic diseases has necessitated the development of innovative treatment protocols that can be applied across diverse patient populations. This study aims to evaluate the efficacy of novel treatment protocols in improving patient outcomes in chronic disease management. Leveraging a multinational cohort from Portugal, Spain, and Peru, we conducted a randomized controlled trial involving 1,200 patients presenting with various chronic conditions. The study employed a mixed-methods approach, integrating quantitative assessments with qualitative interviews to capture a holistic view of treatment efficacy and patient satisfaction. Our findings highlight the potential of tailored treatment protocols to enhance therapeutic outcomes, with significant improvements noted in patient-reported quality of life measures and reduced hospitalization rates. Furthermore, the cost-effectiveness of these protocols was analyzed, indicating potential savings for healthcare systems. In conclusion, the study underscores the importance of customizing treatment approaches to cater to the specific needs of patients while considering cultural and regional differences. These insights can inform policy-making and clinical practices in the effective management of chronic diseases worldwide.